Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…

Biotechnology

US, Tarrytown [HQ]

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Officers & BofD Beta

All directors and officers of Regeneron Pharmaceuticals, Inc. are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).

Form 3/4/5
Proxy DEF-14A

Total Compensation

Shows the total compensation per mentioned executive and board director.
Each datapoint refers the most recent appearance of the corresponding person.

- No data, only available if we have DEF 14A compensations in place -

Officers

Name & Position	Research
Van Plew Daniel P EVP & General Mgr, Industrial	Transactions Compensations Speech	12/18/24 [Form 4]
Stahl Neil EVP Research and Development	Transactions Compensations Speech	12/18/24 [Form 4]
Pitofsky Jason VP Controller	Transactions Compensations Speech	12/18/24 [Form 4]
Murphy Andrew J EVP Research	Transactions Compensations Speech	12/18/24 [Form 4]
Mccourt Marion EVP Commercial	Transactions Compensations Speech	12/18/24 [Form 4]
Larosa Joseph J EVP General Counsel and Secret	Transactions Compensations Speech	12/18/24 [Form 4]
Fenimore Christopher R. SVP Finance & CFO	Transactions Compensations Speech	12/18/24 [Form 4]
Schleifer Leonard S Bd. Co-Chair, President & CEO Also inside the BofD	Transactions Compensations Speech	06/13/24 [Form 4]
Yancopoulos George Bd. Co-Chair, President & CSO Also inside the BofD	Transactions Compensations Speech	06/12/24 [Form 4]
Landry Robert E EVP Finance CFO	Transactions Compensations Speech	02/06/24 [Form 4]

Board of Directors (BofD)

Name & Position	Research
Schenkein David P Director	Transactions Compensations Speech	01/06/25 [Form 4]
Thompson Craig B. Director	Transactions Compensations Speech	01/06/25 [Form 4]
Coles N Anthony Director	Transactions Compensations Speech	01/06/25 [Form 4]
Zoghbi Huda Y Director	Transactions Compensations Speech	01/06/25 [Form 4]
Ryan Arthur F Director	Transactions Compensations Speech	01/06/25 [Form 4]
Guarini Kathryn Director	Transactions Compensations Speech	01/06/25 [Form 4]
Goldstein Joseph L Director	Transactions Compensations Speech	01/06/25 [Form 4]
Brown Michael S Director	Transactions Compensations Speech	01/06/25 [Form 4]
Bassler Bonnie L Director	Transactions Compensations Speech	01/06/25 [Form 4]
Sing George L Director	Transactions Compensations Speech	01/03/25 [Form 4]